Late rectal complications after prostate brachytherapy for localized prostate cancer

Cancer

Volumn 115, Issue 9, 2009, Pages 1827-1839

  Phan, Jack ^a   Swanson, David A ^a   Levy, Lawrence B ^a   Kudchadker, Rajat J ^a   Bruno, Teresa L ^a   Frank, Steven J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Argon plasma coagulation; Brachytherapy; Colonoscopy; Prostate cancer; Rectal complications

Indexed keywords

AMINOSALICYLIC ACID; FORMALDEHYDE; MESALAZINE; NARCOTIC AGENT; OXYGEN; PLACEBO; PREDNISONE; SALAZOSULFAPYRIDINE; SHORT CHAIN FATTY ACID; STEROID; SUCRALFATE;

ANAL STENOSIS; ARGON PLASMA COAGULATION; BRACHYTHERAPY; CAUTERIZATION; CLINICAL FEATURE; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COLOSTOMY; CONSERVATIVE TREATMENT; FECES INCONTINENCE; HUMAN; HYPERBARIC OXYGEN; ILEUS; IMAGING; IMPLANTATION; INTESTINE OBSTRUCTION; LIFESTYLE MODIFICATION; LOW LEVEL LASER THERAPY; MEDICAL LITERATURE; MORBIDITY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROCTITIS; PROSTATE; PROSTATE CANCER; PROSTATE CARCINOMA; RADIATION EXPOSURE; RECTAL PAIN; RECTUM; RECTUM BIOPSY; RECTUM DISEASE; RECTUM FISTULA; RECTUM HEMORRHAGE; RECTUM INJURY; RECTUM RESECTION; RECTUM STENOSIS; RECTUM ULCER; REVIEW; SEPSIS; WOUND DEHISCENCE;

BRACHYTHERAPY; GASTROINTESTINAL HEMORRHAGE; GUIDELINES AS TOPIC; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RECTAL DISEASES; RISK FACTORS; TIME FACTORS;

EID: 65649089481     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24223     Document Type: Review

References (96)

1. Greenlee R. Hill-Harmon M. Murray T. Thun M. Cancer statistics. 2001. CA Cancer J Clin. 2001;51:15-36.
2. U. S. Cancer Statistics Working Group. United States Cancer Statistics: 2004Incidence and Mortality. Atlanta. Ga: Department of Health and Human Services. Centers for Disease Control and Prevention. and National Cancer Institute; 2007.
3. Peter D. C. John C. B. John E. S. Robert M. M. William C. 10-Year biochemical (prostate-specific antigen) control of prostate cancer with 1251 brachytherapy. Int J Radiat Oncol BiolPhys. 2001;51:31-40.
4. D'Amico A. V. Whittington R. Malkowicz S. B. et al. Biochemical outcome after radical prostatectomy. external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA. 1998;280:969-974.
5. Frank S. J. Pisters L. L. Davis J. Lee A. K. Bassett R. Kuban DA. An assessment of quality of life following radical prostatectomy. high dose external beam radiation therapy and brachytherapy iodine Implantation as monotherapies for localized prostate cancer.J Urol. 2007;177:2151-2156.
6. Wei J. T. Dunn R. L. Sander H. M. et al. Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer. J Clin Oncol. 2002;20:557-566.
7. Cotti G. Seld V. Araujo S. Silve e Souza A. H. Jr.Kiss DR, Habr-Gama A. Conservative therapies for hemorrhagic radiation proctitis: a review. Rev Hasp Clin Fac Med Sao Paulo. 2003;58:284-292.
8. Anseline P. F. Lavery I. C. Fazio V. W. Jagelman D. G. Weakley FL. Radiation injury of the rectum: evaluation of surgical treatment.Ann Surg. 1981; 194:716-724.
9. Gilinsky N. H. Burns D. G. Barbezat G. O. Levin W, Myers H. S. Marks IN. The natural history of radiation-induced proctosigmoiditis: an analysis of 88 patients. Q J Med. 1983;52:40-53.
10. Haboubi N. Path M, Schofield P, Rowland P. The light and electron microscopic features of early and late phase radiation-Induced proctitls. Am J Gastroenterol. 1988;83: 1140-1144.
11. Tagkalidis P. P. Tjandra J. J. Chronic radiation proctitis. Aust N ZJ Surg. 2001;71:230-237.
12. Rothenberger B. Lisehora G. Radiation proctitls. Semin Colon Rectal Surg. 1993;4:240-248.
13. Ajlouni M.Radiation-induced proctitis. Curr Treat Options Gastroenterol. 1999;2:20-26.
14. Zelefsky M. J. Hollister T. Raben A. Matthews S. Wallner KE. Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer. lnt J Radiat Oncol Biol Phys. 2000;47:1261-1266.
15. Zelefsky M. J. Yamada Y. Cohen GN, et al. Five-year outcome of Intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancer. lnt J Radiat Oncol Biol Phys. 2007;67:65-70.
16. Gelblum D. Y. Potters L. Rectal complications associated with transperineal interstitial brachytherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48:119-124.
17. Waterman FM. Dicker AP. Probability of late rectal morbidity in I-125 prostate brachytherapy. lnt J Radiat Oncol BiolPhys.2003;55:342-353.
18. Haselton P. Carr N. Schofield P. Vascular changes in radiation bowel disease.Histopathology. 1985;9:517-534.
19. Theodorescu D. Gillenwater J. Koutrouvelis P. Prostatourethral-rectal fistula after prostate brachytherapy. Cancer. 2000;89:2085-2091.
20. Kang S. K. Chou R. H. Dodge R. K. et al. Gastrointestinal toxicity of transperineal interstitial prostate brachytherapy. lnt J Radiat Oncol Biol Phys. 2002;53:99-103.
21. Shah J. N. Ennis R. D. Rectal toxicity profile after transperineal Interstitial permanent prostate brachytherapy: use of a comprehensive toxicity scoring system and identification of rectal doslmetric toxicity predictors. lnt J Radiat Oncol Biol Phys. 2006;64:817-824."
22. Blasko J. C. Ragde H. Schumacher D. Transperineal percutaneous iodine-125 implantation for prostatic carcinoma using transrectal ultrasound and template guidance. Endocurietherapy Hyperthemia Oncol. 1987;3:131-139.
23. Grimm PD, Blasko J. C. Ragde H. Ultrasound guided transperineal implantation of iodine-125 and palladium-103 for the treatment of early stage prostate cancer. Atlas Urol Clin North Am. 1994;2;113-125.
24. Wallner K. Roy J. Harrison L. Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma. J Clin Oncol. 1996; 14: 449-453.
25. Blasko J. C. Wallner K. Grimm P. D. Ragde H. Prostate specific antigen based disease control following ultrasound guided 125-iodine implantation for stage T1/T2 prostatic carcinoma.J Urol. 1995;154:1096-1099.
26. Ragde H. Elgamal A, Snow P, et al. Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45 Gy external beam irradiation in the treatment of patients with clinically localized low to high Gleason grade prostate carcinoma. Cancer. 1998;83:9894001.
27. Beyer D. Priestley J.Biochemical disease-free survival following 1-125 prostate implantation. Int J Radiat Oncol Biol Phys. 1997;37:559-563.
28. Hu K. Wallner K. E. Clinical course of rectal bleeding following I-125 prostate brachytherapy.Int J Radiat Oncol Biol Phys. 1998;4l:263-265.
29. Syed A, Puthawala A. Austin P. et al. Temporary iridium- 192 implant in the management of carcinoma of the prostate. Cancer. 1992;69;2515-2524.
30. Willins J, Wallner K.CT based dosimetry for transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1997;39:347-353.
31. Goffinet D, Martinez A, Freiha F, et al. 125-I odine prostate implants for recurrent carcinomas after external beam irradiation: preliminary results. Cancer. 1980;45:2717-2724.
32. Abadir R. Ross G. J. Weinstein S. Carcinoma of the prostate treated by pelvic node dissection. iodine-125 seed implant and external radiation: a study of rectal complications. Clin Radial. 1984;35:359-361.
33. Jordan G. G. Lynch D. W. Warden S. S. McGraw JD, Hoffmann GC, Schellhammer PF. Major rectal complications following interstitial implantation of 125-lodine for carcinoma of the prostate.J Urol. 1985;134:1212-1214.
34. Kleinberg L. Wallner K. Roy J, et al. Treatment-related symptoms during the first year following transperineal 125- I prostate implantation. Int J Radiat Oncol Biol Phys. 1994;28:985-990.
35. Merrick G. S. Butler W. M. Dorsey A. T. Lief J. H. Walbert H. L. Blatt HJ.Rectal dosimetric analysis following prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1999;43:1021-1027.
36. Wallner K. Roy J. Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys. 1995;32:465-471.
37. Zelefsky M. J. Yamada Y. Cohen G. A. et al. Intraoperative real-time planned conformal prostate brachytherapy; postimplantation dosimetric outcome and clinical implications. Radiother Oncol. 2007;84:185-189.
38. Phan J. Swanson DA, Kuban D. A. et al. Long-term rectal complications following permanent prostate brachytherapy at the University of Texas M. D. Anderson Cancer Center. Presented at the 90th Annual Meeting of the American Radium Society. '"Toward Individualized Cancer Therapy." Dana Point. California. May 3-7. 2008.
39. Martin A.-G. Roy J. Beaulieu L. Pouliot J. Harel F. Vigneault E. Permanent prostate implant using high activity seeds and inverse planning with fast simulated annealing algorithm: a 12-year Canadian experience. Int J Radiat Oncol Biol Phys. 2007;67:334-341.
40. Kudchadker R. J. Swanson D. A. Kuban D. A. Lee A. K. Bruno T. L. Frank SJ. Is a loose-seed nomogram still valid for prostate brachytherapy in a stranded-seed era? Int j Radiat Oncol Biol Phys. 2008;72:623-627.
41. Albert M. Tempany C. M. Schultz D. et al. Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy. Cancer. 2003;98: 949-954.
42. Snyder K. M. Stock R. G. Hong S. M. Lo Y. C. Stone NN. Defining the risk of developing grade 2 proctitis following I-125 prostate brachytherapy using a rectal dose-volume histogram analysis. Int J Radiat Oncol Biol Phys. 2001;50: 335-341.
43. Kaye K. W. Olson D. J. Payne JT. Detailed preliminary analysis of iodine-125 implantation for localized prostate cancer using percutaneous approach.J Urol. 1995;45:1020-1025.
44. Bondesen S, Rasmussen S. Rask-Madsen J, et al.5-Aminosalicylic acid in the treatment of inflammatory bowel disease. Acta Med Scand. 1987:221:227-242.
45. Kochhar R, Patel F. Dhar A. et al. Radiation-induced proctosigmoiditis. Prospective. randomized. double-blind controlled trial of oral sulfasalazine plus rectal steroids versus rectal sucralfate. Dig Dis Sci. 1991:36:103-107.
46. Hong J. Park W. Ehrenpreis E. Review article; current therapeutic options for radiation proctopathy. Aliment Pharmacol Ther. 2001;15:1253-1262.
47. Baum C. A. Biddle W. L. Miner PB Jr. Failure of 5-aminosalicylic acid enemas to improve chronic radiation proctitis. Dig Dis Sci. 1989;34:758-760.
48. Goldstein F, Khoury J. Thorton J.Treatment of chronic radiation enteritis and colitis with salicylazosulfapyridine and systemic corticosteroids. Am J Gastroenterol. 1976;65: 201-208.
49. Ladas S. D. Raptis SA. Sucralfate enemas in the treatment of chronic post-radiation proctitis. Am J Gastroenterol. 1989; 84:1587-1589.
50. Triantafillidis J. Dadioti P. Nicolakis D. Mericas E. High, doses of 5-aminosalicylic acid enemas in chronic radiation proctitis; comparison with betamethasone enemas. Am J Gastroenterol. 1990;85:1537-1537.
51. Sasai T. Hiraishi H, Suzuki Y, Masuyama H. Ishida M. Terano A. Treatment of chronic post-radiation proctitis with oral administration of sucralfate. Am J Gastroenterol. 1998;93:1593-1595.
52. Kochhar R. Sritam P. Sharma S. Goel R. Patel F. Natural history of late radiation proctosigmoiditis treated with topical sucralfate suspension. Dig Dis Sci. 1999;44:973-978.
53. Cook SI, Sellin JH. Review article: short chain fatty acids in health and disease. Aliment Pharmacol Ther. 1998;12:499-507.
54. Scheppach W. Christl S. Bartram H. Effects of short-chain fatty acids on the inflamed colonic rnucosa. Scand J Gastroenterol. 1997;222 (suppl):53-57.
55. Pinto A. Fidalgo P. Cravo M. et al. Short chain fatty acids are effective in short-term treatment of chronic radiation proctopathy: randomized, double-blind. controlled trial. Dis Colon Rectum. 1999;42:788-795.
56. Vernia P. Fracasso P. Casale P. et al. Topical butyrate for acute radiation proctitis: randomised. crossover trial. Lancet. 2000;356:1232-1235.
57. Chen F. King D. Talley N. Short-chain fatty acid enemas for chronic radiation proctitis: a pilot study [abstract]. Dis Colon Rectum. 1996;39:A34.
58. Talley N. Chen F. King D. Jones M. Talley N. Short-chain fatty acids in the treatment of radiation proctitis: a randomized. double-blind. placebo-controlled. cross-over pilot trial. Dis Colon Rectum. 1997;40:1046-1050.
59. Warren D. Feehan P. Slade J. Cianci P. Chronic radiation proctitis treated with hyperbaric oxygen. Undersea Hyperb Med. 1997;24:181-184.
60. Woo T. Joseph D. Oxer H. Hyperbaric oxygen treatment for radiation proctitis. Int J Radiat Oncol Biol Phys. 1997;38:619-622.
61. Clarke RE, Tenorio L. M. Hussey J. R. et al. Hyperbaric oxygen treatment of chronic refractory radiation proctitis: a randomized and controlled double-blind crossover trial with long-term follow-up. Int J Radiat Oncol Biol Phys. 2008;72:134-l43.
62. Lucarotti M. Mountford R. Bartolo D. Surgical management of intestinal radiation injury. Dis Colon Rectum. 1991;34:865-869.
63. Jao S. Beart R. Gunderson L. Surgical treatment of radiation injuries of the colon and rectum. Am J Surg. 1985;2:272-277.
64. de Parades V. Etienney I. Bauer P, et al.Formalin application in the treatment of chronic radiation-induced hemorrhagic proctitis-an effective but not risk-free procedure: a prospective study of 33 patients. Dis Colon Rectum. 2005;48:1535-1541.
65. Wilson S. A. Rex DK. Endoscopic treatment of chronic radiation proctopathy. Curr Opin Gastroenterol. 2006;22;536-549.
66. Parikh S. Hughes C, Salvati E. et al. Treatment of hemorrhagic radiation proctitis with 4 percent formalin. Dis Colon Rectum. 2003;46:596-600.
67. Mathai V. Seow-Chen F. Endoluminal formalin therapy for haemorrhagic radiation proctitis. Br J Surg. 1995;82:190-190.
68. Seow-Chen F. Goh H. Eu K. Ho Y. Tay S. A simple and effective treatment for hemorrhagic radiation proctopathy using formalin. Dis Colon Rectum. 1993;36:135-138. (Pubitemid 23057758)
69. Sadarides T. King D, Franklin J. Doolas A. Formalin installation for refractory radiation-induced hemorrhagic proctitis. Dis Colon Rectum. 1996;39:196-199.
70. Biswal B. Lal P. Rath G. Shukla N. Mohanti B. Deo S. Intrarectal formalin application. an effective treatment for grade III haemorrhagic radiation proctitis. Radiother Oncol. 1995;35:212-225.
71. Counter S. Froese D. Hart M.Prospective evaluation of formalin therapy for radiation proctitis. Am J Surg. 1999;177:396-398. (Pubitemid 29252809)
72. Roche B. Chauterns R. Marti M. Application of formaldehyde for treatment of hemorrhagic radiation-induced proctitis. World J Surg. 1996;20:1092-1095. (Pubitemid 26322102)
73. Yegappan M. Ho Y. Nyam D. Leong A. Eu K. Sweo C. The surgical management of colorectal complications from irradiation for carcinoma of the cervix. Ann Acad Med Singapore. 1998;27:627-630.
74. Jensen D. Jutabha R. Machicado G. J. et al. Prospective randomized comparative study of bipolar electrocoagulation versus heater probe for treatment of chronically bleeding internal hemorrhoids. Gastrointest Endosc. 1997;46:435-443. (Pubitemid 27498391)
75. Fuentes D. Monserat R. Isern A. Colitis due to radiation: endoscopic management with heat probe [in Spanish]. G E N. 1993;47:165-167.
76. Davila A. Koch J. Cello J. Management of chronic radiation proctitis [abstract]. Gastrointest Endosc. 1996;43:365. (Pubitemid 126802194)
77. Viggiano T. Zighelboim J. Ahlquist D, Gostout C. Wang K. Larson M. Endoscopic Nd:YAG laser coagulation of bleeding from radiation proctopathy. Gastrointest Endosc. 1993;39:513-517. (Pubitemid 23228190)
78. Taylor J. DiSario J. Buchi K. Argon laser therapy for hemorrhagic radiation proctitis: long-term results. Gastrointest Endosc. 1993;39:641-644. (Pubitemid 23282516)
79. Carbatzas C. Spencer G. Thorpe S. Sargeant L. Brown S. Nd:YAG laser treatment for bleeding from radiation proctitis. Endoscopy. 1996;28:497-500.
80. Buchi K. Radiation proctitis: therapy and prognosis. JAMA. 1991;265:1180-1180.
81. Alexander T. Dwyer R. Endoscopic Nd:YAG laser treatment of severe radiation injury of the lower gastrointestinal tract: long-term follow-up. Gastrointest Endosc. 1988;34: 407-411.
82. Buchi K. Dixon J. Argon laser treatment of hemorrhagic radiation proctitis. Gastrointest Endosc. 1987;33:27-30. (Pubitemid 17010107)
83. Chapuis P. Dent O. Bokey E. et al. The development of a treatment protocol for patients with chronic radiationinduced rectal bleeding. Aust N ZJ Surg. 1996;66:680-685. (Pubitemid 26323491)
84. Taylor J. DiSario J. Bjorkman D. KTP laser therapy for bleeding from chronic radiation proctopathy. Gastrointest Endosc. 2000;52:353-357.
85. Ginsberg G. Barkun A. Bosco J. et al. The argon plasma coagulator: February 2002. Gatstrointest Enclosc. 2002;55: 807-810.
86. Villavicencio R. Rex D. Rahmani E. Efficacy and complications of argon plasma coagulation for hematochezia related to radiation proctopathy. Gastrointest Enclose. 2002;55:70-74. (Pubitemid 41122927)
87. Kaasis M. Oberti F. Burtin P. Beyer J. Argon plasma coagulation for the treatment of hemorrhagic radiation proctitis. Endoscopy. 2000;32;673-676.
88. Tarn W. Moore J. Schoeman M. Treatment of radiation proctitis with argon plasma coagulation. Endoscopy. 2000;32:667-671.
89. Silva R. Correia M. Dias L. Viana H. Argon plasma coagulation therapy for hemorrhagic radiation proctosigmoiditis. Gastrointest Endosc. 1999;50:221-224. (Pubitemid 29380369)
90. Fantin A. Binek J. Suter W. Meyenberger C. Argon beam coagulation for treatment of symptomatic radiation-induced proctitis. Gastrointest Endosc. 1999;49:515-518. (Pubitemid 29217344)
91. Sebastian S. O'Conner H. O'Morain C. Buckley M. Argon plasma coagulation as first-line treatment for chronic radiation proctopathy. J Gastroenterol Hepatol. 2004; 19:1169-1173.
92. Chutkan R. Lipp A. Waye J. The argon plasma coagulator: a new and effective modality for treatment of radiation proctitis [abstract]. Gastrointest Endosc. 1997;45: AB27. (Pubitemid 127790554)
93. Rotondano G. Bianco M. Marmo R. Piscopo R. Cipolletta L. Long-term outcome of argon plasma coagulation therapy for bleeding caused by chronic radiation proctopathy. Dig Liver Dis. 2003;35:806-810.
94. Postgate A. Saunders B. Tjandra J. Vargo J. Argon plasma coagulation in chronic radiation proctitis. Endoscopy. 2007;39:361-365. (Pubitemid 46605938)
95. Baxter N. Tepper J. Durham S. R. Rothenberger D. A. Virnig BA. Increased risk of rectal cancer aiter prostate radiation: a population-based study. Gastroenterology. 2005;128:6819-824. (Pubitemid 41660673)
96. Tran A. Wallner K. Merrick G. S. et al. Rectal fistulas after prostate brachytherapy. Int J Radiat Oncol Biol Phys. 2005;63:150-154. (Pubitemid 41583553)